Strategic Initiative
Slingshot members are tracking this corporate initiative:
Novo Nordisk (NVO) Submits Supplemental New Drug Application in U.S and Canada to Include the Cardiovascular Outcomes on Labels From LEADER Study for Victoza in Type 2 diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVO |
|
|
||||
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Oct 26, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2017
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Supplemental New Drug Application, Cardiovascular Outcomes, Leader Study, Victoza, Type 2 Diabetes
